Tara Alire
About Tara Alire
Tara Alire serves as the Director of Business Development and Corporate Strategy at Mammoth Biosciences, where she focuses on advancing CRISPR technology. She has a diverse background in biopharma partnerships and strategic consulting, having held various roles at companies such as Invitae, UCLA Health, and Amgen.
Current Role at Mammoth Biosciences
Tara Alire serves as the Director of Business Development & Corporate Strategy at Mammoth Biosciences, a position she has held since 2022. In this role, she focuses on leveraging the diversity of nature to advance CRISPR technology. Her responsibilities include engaging in comprehensive business development activities, which encompass search and evaluation, transactions, and R&D strategy in the gene editing and diagnostics sectors.
Previous Experience at Invitae
Prior to her current role, Tara Alire worked at Invitae from 2020 to 2022. She initially served as Program Manager for Biopharma Partnerships for two years, where she played a key role in establishing a real world data ecosystem centered around genomics. She later transitioned to the position of Director of Business Development for seven months in 2022, where she focused on corporate development and strategic partnerships.
Educational Background
Tara Alire holds a Doctor of Pharmacy (PharmD) degree from the University of Southern California, where she studied Clinical, Hospital, and Managed Care Pharmacy. She also earned a Bachelor of Science (BS) in Microbiology from UC San Diego. Her educational background provides a strong foundation for her expertise in biopharma and healthcare.
Professional Experience in Healthcare
Tara Alire has a diverse professional background in the healthcare and biopharma industries. She has held various roles, including a Pharmacy Intern at UCLA Health, a Senior Clinical Research Coordinator at UC San Diego Health, and an Associate Consultant at ZS. Her experience also includes internships at Amgen and Allergan, where she contributed to scientific communications and clinical development, respectively.
Strategic Contributions and Advisory Roles
In her career, Tara Alire has advised Fortune 500 companies on biopharma topics, including corporate development and go-to-market strategy. She supports board meetings and investor relations through her strategic role in business development and corporate strategy, demonstrating her capability to influence high-level decision-making in the industry.